Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Karolinska Development’s portfolio company Aprea Therapeutics secures funding of USD 5.5 million STOCKHOLM, SWEDEN, February 28, 2023...
Karolinska Development’s portfolio company Modus Therapeutics presents positive results from a clinical trial of sevuparin STOCKHOLM, SWEDEN...
Year-end Report - January-December 2022 STOCKHOLM – 17 February 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its...
Karolinska Development’s portfolio company Dilafor reports maintained effect in the extension study of tafoxiparin STOCKHOLM, SWEDEN –...
Karolinska Development’s portfolio company Umecrine Cognition is granted Orphan Drug Designation by the FDA for golexanolone STOCKHOLM...
Karolinska Development’s portfolio company Aprea Therapeutics doses the first patient in a clinical phase 1/2a study of ATRN-119 STOCKHOLM...
Karolinska Development's portfolio company OssDsign has published a case report from the TOP FUSION study in a scientific journal...
Karolinska Development’s portfolio company Umecrine Cognition presents preclinical data showing effect of golexanolone in a Parkinson’s disease...
Karolinska Development’s portfolio company Dilafor has completed recruitment to an extension study of tafoxiparin STOCKHOLM, SWEDEN –...
Karolinska Development's portfolio company OssDsign has presented positive long-term data for OssDsign Cranial PSI STOCKHOLM, SWEDEN...
Karolinska Development's portfolio company OssDsign has completed a directed share issue of approximately SEK 65.6 million STOCKHOLM...
Interim Report - January-September 2022 STOCKHOLM – 18 November 2022. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its...
Karolinska Development invests in the Danish dermatology company Henlez STOCKHOLM, SWEDEN, October 24, 2022. Karolinska Development AB...
Karolinska Development’s portfolio company Umecrine Cognition presents positive results from a preclinical study of golexanolone STOCKHOLM...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관